Huntsman Corporation will announce its third quarter 2026 financial results on November 3, 2026, with a conference call at 9:00 a.m. ET. The earnings release and detailed financial statements will be published after market close on November 2. Investors can access the earnings presentation and participate in a Q&A session via webcast. Huntsman is a global chemical manufacturer with $6 billion in 2025 revenue, operating in 25 countries with about 6,000 employees.
Huntsman Corporation's upcoming third quarter 2026 results announcement provides context for market watchers. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Oct 07, 2026 03:12 WIB: Of 38 priced US Basic Materials stocks tradable on Pluang, 27 rose and 10 fell today. Notable movers include Aspen Aerogels Inc (ASPN) at USD 5.81 with a 1-day change of +2.11% and a typical hold time of 13 days, Agnico Eagle Mines Ltd (AEM) at USD 186.98 with a +1.99% change and a typical hold time of 56 days, and Linde PLC (LIN) at USD 491.90 with a +1.97% change and a typical hold time of 88 days.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...
